Sanofi (SNY) Q4 2022 Earnings Call Transcript : vimarsana.co

SNY earnings call for the period ending December 31, 2022.

Related Keywords

Germany , Chatillon , France General , France , Japan , Argentina , Italy , China , Canada , Spain , Turkey , Chinese , Luisa Hector , Graham Parry , Richard Parkes , Matthew Weston , Tim Anderson , Peter Verdult Citi , Luisa Hector Berenberg , Thomas Triomphe , Sanofi Pasteur , Paul Hudson , Richard Parkes Exane , Julie Van Ongevalle , Mark Purcell , Steve Scala Cowen , Steve Scala , Aubagio Lo , Eva Schaefer Jansen , Olivier Charmeil , America Merrill Lynch , Keyur Parekh Goldman Sachs , Keyur Parekh , Mark Purcell Morgan Stanley , Peter Welford Jefferies , John Reed , Vidprevtyn Beta , Sanofi Genzyme , Enregistrement Universel , Richard Vosser Jpmorgan , Peter Verdult , Peter Welford , Richard Vosser , Morgan Stanley , Tim Anderson Wolfe Research Analyst , Hepatic Assessment Committee , European Commission , Goldman Sachs , World Health Organization , Credit Suisse , Graham Parry Bank , Pfizer , Global Head Of Research , Company Analyst , Bill Sibold , Jean Baptiste De Chatillon , Raise Hand , Motley Fool Stock Advisor , Stock Advisor , New England Journal , Cold Agglutinin , Vice President , Prurigo Nodularis , Aubagio Loe , Protection Beyond Flu , Fluzone High Dose , After Germany , Effective January , Dont Hide , East Asian , Euro Effie , Global Head , Capital Markets , Protection Beyond , Tamiflu Cialis , Executive Vice President , Berenberg Capital Markets , Wolfe Research ,